FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998045177> ?p ?o ?g. }

• W1998045177 endingPage "644" @default.
• W1998045177 startingPage "638" @default.
• W1998045177 abstract "BackgroundA novel classification of pulmonary adenocarcinoma (ADC) distinguishing five growth patterns has been established by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. There is evidence that an additional cribriform pattern associates with a distinct clinical behavior.MethodsWe evaluated the predominant growth pattern of 674 resected ADC as recommended by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society, including the cribriform pattern. The predominant pattern type was correlated with clinical, molecular, and survival data.ResultsTwo hundred forty-eight (36.8%) of the pulmonary ADC were solid, 207 (30.6%) were acinar, 101 (15%) were papillary, 55 (8.2%) were micropapillary, 35 (5.2%) were lepidic, and 28 cases (4.2%) were cribriform predominant (cpADC). Minor cribriform components were frequently observed (28.6% of all cases). cpADC showed the second highest proliferative capacity of all patterns, no somatic mutations in the epidermal growth factor receptor (p = 0.001) and a high rate of KRAS mutations. Overall survival (OS) of patients with cpADC (mean OS: 62.7 months) ranged in between survival times of patients with acinar (mean OS: 71.3 months) and solid predominant ADC (mean OS: 54.5 months); cpADC was associated with the worst disease-free survival (DFS) of all patterns (mean DFS: 36.9 months). Both associations were confirmed by multivariate analysis (p < 0.01 for both OS and DFS). Hazard ratios for cpADC were 1.72 for OS and 2.99 for DFS, with lepidic predominant ADC set as reference (hazard ratio: 1).ConclusionsOur data support the introduction of cpADC as a novel category into future morphology based on pulmonary ADC classifications. Further international studies are required to validate the reported clinicopathological associations of the cribriform pattern. A novel classification of pulmonary adenocarcinoma (ADC) distinguishing five growth patterns has been established by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. There is evidence that an additional cribriform pattern associates with a distinct clinical behavior. We evaluated the predominant growth pattern of 674 resected ADC as recommended by the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society, including the cribriform pattern. The predominant pattern type was correlated with clinical, molecular, and survival data. Two hundred forty-eight (36.8%) of the pulmonary ADC were solid, 207 (30.6%) were acinar, 101 (15%) were papillary, 55 (8.2%) were micropapillary, 35 (5.2%) were lepidic, and 28 cases (4.2%) were cribriform predominant (cpADC). Minor cribriform components were frequently observed (28.6% of all cases). cpADC showed the second highest proliferative capacity of all patterns, no somatic mutations in the epidermal growth factor receptor (p = 0.001) and a high rate of KRAS mutations. Overall survival (OS) of patients with cpADC (mean OS: 62.7 months) ranged in between survival times of patients with acinar (mean OS: 71.3 months) and solid predominant ADC (mean OS: 54.5 months); cpADC was associated with the worst disease-free survival (DFS) of all patterns (mean DFS: 36.9 months). Both associations were confirmed by multivariate analysis (p < 0.01 for both OS and DFS). Hazard ratios for cpADC were 1.72 for OS and 2.99 for DFS, with lepidic predominant ADC set as reference (hazard ratio: 1). Our data support the introduction of cpADC as a novel category into future morphology based on pulmonary ADC classifications. Further international studies are required to validate the reported clinicopathological associations of the cribriform pattern." @default.
• W1998045177 created "2016-06-24" @default.
• W1998045177 creator A5006783214 @default.
• W1998045177 creator A5018744564 @default.
• W1998045177 creator A5026607584 @default.
• W1998045177 creator A5052004888 @default.
• W1998045177 creator A5065509965 @default.
• W1998045177 creator A5081978650 @default.
• W1998045177 creator A5085505239 @default.
• W1998045177 date "2015-04-01" @default.
• W1998045177 modified "2023-10-17" @default.
• W1998045177 title "Prognostic Impact and Clinicopathological Correlations of the Cribriform Pattern in Pulmonary Adenocarcinoma" @default.
• W1998045177 cites W1484218853 @default.
• W1998045177 cites W1570858791 @default.
• W1998045177 cites W1975651143 @default.
• W1998045177 cites W1980610830 @default.
• W1998045177 cites W1984065244 @default.
• W1998045177 cites W1986272045 @default.
• W1998045177 cites W1996756040 @default.
• W1998045177 cites W2021481801 @default.
• W1998045177 cites W2032995263 @default.
• W1998045177 cites W2042239506 @default.
• W1998045177 cites W2049674541 @default.
• W1998045177 cites W2082851237 @default.
• W1998045177 cites W2092578019 @default.
• W1998045177 cites W2097152112 @default.
• W1998045177 cites W2126661558 @default.
• W1998045177 cites W2127009358 @default.
• W1998045177 cites W2139556177 @default.
• W1998045177 cites W2150213931 @default.
• W1998045177 cites W2157297232 @default.
• W1998045177 cites W2163149604 @default.
• W1998045177 cites W2187380765 @default.
• W1998045177 doi "https://doi.org/10.1097/jto.0000000000000490" @default.
• W1998045177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25634008" @default.
• W1998045177 hasPublicationYear "2015" @default.
• W1998045177 type Work @default.
• W1998045177 sameAs 1998045177 @default.
• W1998045177 citedByCount "76" @default.
• W1998045177 countsByYear W19980451772015 @default.
• W1998045177 countsByYear W19980451772016 @default.
• W1998045177 countsByYear W19980451772017 @default.
• W1998045177 countsByYear W19980451772018 @default.
• W1998045177 countsByYear W19980451772019 @default.
• W1998045177 countsByYear W19980451772020 @default.
• W1998045177 countsByYear W19980451772021 @default.
• W1998045177 countsByYear W19980451772022 @default.
• W1998045177 countsByYear W19980451772023 @default.
• W1998045177 crossrefType "journal-article" @default.
• W1998045177 hasAuthorship W1998045177A5006783214 @default.
• W1998045177 hasAuthorship W1998045177A5018744564 @default.
• W1998045177 hasAuthorship W1998045177A5026607584 @default.
• W1998045177 hasAuthorship W1998045177A5052004888 @default.
• W1998045177 hasAuthorship W1998045177A5065509965 @default.
• W1998045177 hasAuthorship W1998045177A5081978650 @default.
• W1998045177 hasAuthorship W1998045177A5085505239 @default.
• W1998045177 hasBestOaLocation W19980451771 @default.
• W1998045177 hasConcept C121608353 @default.
• W1998045177 hasConcept C126322002 @default.
• W1998045177 hasConcept C142724271 @default.
• W1998045177 hasConcept C143998085 @default.
• W1998045177 hasConcept C204232928 @default.
• W1998045177 hasConcept C207103383 @default.
• W1998045177 hasConcept C2776256026 @default.
• W1998045177 hasConcept C2777714996 @default.
• W1998045177 hasConcept C2781182431 @default.
• W1998045177 hasConcept C2781187634 @default.
• W1998045177 hasConcept C2909818935 @default.
• W1998045177 hasConcept C44249647 @default.
• W1998045177 hasConcept C526805850 @default.
• W1998045177 hasConcept C71924100 @default.
• W1998045177 hasConcept C90924648 @default.
• W1998045177 hasConceptScore W1998045177C121608353 @default.
• W1998045177 hasConceptScore W1998045177C126322002 @default.
• W1998045177 hasConceptScore W1998045177C142724271 @default.
• W1998045177 hasConceptScore W1998045177C143998085 @default.
• W1998045177 hasConceptScore W1998045177C204232928 @default.
• W1998045177 hasConceptScore W1998045177C207103383 @default.
• W1998045177 hasConceptScore W1998045177C2776256026 @default.
• W1998045177 hasConceptScore W1998045177C2777714996 @default.
• W1998045177 hasConceptScore W1998045177C2781182431 @default.
• W1998045177 hasConceptScore W1998045177C2781187634 @default.
• W1998045177 hasConceptScore W1998045177C2909818935 @default.
• W1998045177 hasConceptScore W1998045177C44249647 @default.
• W1998045177 hasConceptScore W1998045177C526805850 @default.
• W1998045177 hasConceptScore W1998045177C71924100 @default.
• W1998045177 hasConceptScore W1998045177C90924648 @default.
• W1998045177 hasIssue "4" @default.
• W1998045177 hasLocation W19980451771 @default.
• W1998045177 hasLocation W19980451772 @default.
• W1998045177 hasOpenAccess W1998045177 @default.
• W1998045177 hasPrimaryLocation W19980451771 @default.
• W1998045177 hasRelatedWork W2747512347 @default.
• W1998045177 hasRelatedWork W3030972949 @default.
• W1998045177 hasRelatedWork W3044398268 @default.
• W1998045177 hasRelatedWork W3111812619 @default.
• W1998045177 hasRelatedWork W3119242563 @default.
• W1998045177 hasRelatedWork W3137306121 @default.

• next